InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Pandite Arundathy N., Chief Medical Officer. Officer active across 2 companies, notably Shattuck Labs, Inc.. Cumulatively, 11 disclosures have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €169k. Activity tracked since 10 August 2021. The latest transaction was filed on 12 May 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Pandite Arundathy N.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报11 总计
30,000 股@ US$6.610.035% mcap100.0% 占其流量Common StockSEC:0001193125-26-224669:0
3,195 股@ US$4.155.4% 占其流量Common StockSEC:0001193125-26-024489:0
6,851 股@ US$4.7513.4% 占其流量Common StockSEC:0001193125-26-011837:0
3,211 股@ US$1.161.7% 占其流量Common StockSEC:0000950170-25-010004:0
6,884 股@ US$1.193.7% 占其流量Common StockSEC:0000950170-25-004939:0
2,920 股@ US$9.9912.5% 占其流量Common StockSEC:0000950170-24-009382:0
46,475 股0Common StockSEC:0000950170-24-004648:0
37,875 股0Common StockSEC:0000899243-23-002884:0
2,987 股@ US$3.033.9% 占其流量Common StockSEC:0000899243-23-001683:0
34,738 股0Common StockSEC:0000899243-22-001797:0
4,259 股@ US$0.010.0% 占其流量Common StockSEC:0000899243-21-032549:0
11 条申报中的 11 条
About Pandite Arundathy N.
Arundathy N. Pandite is the Chief Medical Officer at Shattuck Labs, Inc. She is responsible for the medical strategy and innovation within the company. Shattuck Labs focuses on developing advanced therapies. Arundathy plays a key role in guiding medical research and development initiatives.
